With the daily environmental pollution taking a massive toll on our lungs as evidenced by the poor air quality index (AQI) of ...

Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces an oral ...

Human Metapneumovirus (HMPV) is raising concerns with its increasing infections in China and other regions. While the virus ...

Craig Spiby had a rare disorder that made him susceptible to choking and should have been monitored while eating ...

Citation Sample Size/Inclusion Criteria Method/Duration of Cooling Follow-up Findings 27 234 term infants; 116 randomly selected for cooling and 118 selected for control. Sixteen infants were lost ...

Kashmir's leading scientist and gastroenterologist, Prof M Sultran Khuroo writes about the evolution of the Human ...

Ongoing commercial launch of AUCATZYL® on track, with 24 treatment centers fully authorized as of January 10th- National Comprehensive Cancer ...

Cannabis dabbing, an increasingly popular way to consume highly concentrated THC, has been linked to pulmonary and neurologic ...

The Free Press founder and editor Bari Weiss joins 'MediaBuzz' to discuss Mark Zuckerberg ending fact-checking on Facebook.

Its use did not reduce oxygen saturation, nor did patients present any clinical signs of respiratory depression. [50] Table 3 provides the APN with guidelines for dosing and scheduling.

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.